Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary
SEOUL, South Korea, Nov. 25, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. The best ginseng in the world, Korean ginseng became a premium red ginsengThe birth of CheongKwanJang The history of the Korean government managing ginseng and red ginseng dates back...
USANA Assists Philippine Basketball Association As Nutritional Partner
USANA Named The Official Nutritional Supplements of the PBA SALT LAKE CITY, Nov. 25, 2021 /PRNewswire/ -- As USANA, the Cellular Nutrition Company, looks to its 30th anniversary next spring, it continues to showcase and build its elite and diverse athletic partnerships. For more than two decades, USANA has provided high-quality, NSF-tested...
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022
Added 19,066 New Subscribers in 2Q22Revenues Up 9.8% YoY to RMB313.7 Million ($48.7 Million) Gross Profit Up 11.0% YoY to RMB267.5 Million ($41.5 Million)Operating Income Up 15.3% YoY to RMB160.5 Million ($24.9 Million) Non-GAAP Operating Income Up 14.1% YoY to RMB172.8 Million ($26.8 Million)Conference Call to be Held on November 26, 2021, at 8:00 a.m. ET HONG KONG, Nov....
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products
iX Biopharma will receive an initial US$9 million upfront payment Eligible for up to US$239 million in development and sales milestone payments Double digit royalties on future product sales of any licensed product SINGAPORE, Nov. 25, 2021 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C), a specialty pharmaceutical company that develops...
Kintor Pharma Receives IND Clearance by NMPA for KX-826’s Pivotal Study to Treat Male Alopecia Patients
SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the IND application for the pivotal study (phase III stage) of pyrilutamide (KX-826), a potential first-in-class drug developed by Kintor Pharma, for the treatment of male androgenetic alopecia ("AGA") patients was...
Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore
GAITHERSBURG, Md., Nov. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission to the Singapore Health Sciences Authority (HSA) for interim authorization of its COVID-19 vaccine under the Pandemic Special Access Route (PSAR). "Today's filing reinforces...
GOOVIS Head-Mounted Displays Offer the Gift of ‘Good Vision’ This Festive Season
HONG KONG, Nov. 24, 2021 /PRNewswire/ -- As the festive season approaches, GOOVIS, an industry leader in head-mounted display (HMD) technology, is seeking to connect people through the gift of 'Good Vision'. With an impressive range of products suitable for numerous multimedia activities, GOOVIS may be on everyone's wish-list this holiday season. Experts...
Neurophth Therapeutics Strengthens Leadership Team with Appointment of Su Zhang as Chief Financial Officer
SHANGHAI and SAN DIEGO, Nov. 24, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, today announced the recent appointment of Su Zhang, M.B.A., as the Chief Financial Officer (CFO). Su will have board responsibility across corporate and operational...
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
BOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing fully integrated end-to-end contract development and manufacturing services, announced a partnership agreement in...
Waterdrop Inc. to Report Third Quarter 2021 Financial Results on November 30, 2021
BEIJING, Nov. 24, 2021 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2021, before U.S. markets open on Tuesday, November 30, 2021. Waterdrop's management...
